PharmTech News

Articles

The Green Cross facility in Canada will produce intravenous immunoglobulin and albumin.

Green Cross Biotherapeutics Builds Canadian Manufacturing Facility

AmpliPhi announces that its new facility in Slovenia has received cGMP certification to manufacture bacteriophages for clinical trials.

New AmpliPhi Facility Receives cGMP Certification

The pediatric investigation plan provides a clinical development plan for Viaskin Peanut in pediatric population. DBV Technologies will now be able to submit a marketing authorization application in Europe following completion of the Viaskin Peanut Phase III trials.

EMA Pediatric Committee Adopts Positive Opinion on Peanut Allergy Treatment for Children

Teva announces the exclusive launch of its generic equivalent of Actonel in the US.

Teva Launches Generic Version of Actonel

Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or biopolar I disorder.

Innovative Inhaled Antipsychotic Formulation Adasuve Provides Quick and Effective Treatment

Boehringer Ingelheim announces FDA approval of Stiolto Respimat inhaler for the treatment of COPD.

Boehringer Gains FDA Approval of COPD Treatment

Visterra announces partnership with A*STAR to develop VIS513, a monoclonal antibody for the treatment of dengue fever.

Visterra Announces Partnership to Develop a Monoclonal Antibody

Merus and Selexis will combine technology platforms to produce colorectal cancer combination therapy.

Merus and Selexis Receive Grant for Bispecific Antibody Therapeutics

Medicago's new production facility will make plant-based vaccines and therapeutics.

Medicago Plans Vaccine Facility In Quebec City

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The method patent covers the infusion of bendamustine hydrochloride for the treatment of certain blood cancers.

Bio/Pharma News